-
ALS Progression May Be Slowed With CuATSM Treatment, Trial Shows
CuATSM may slow ALS progression, and improve the respiration and cognition of patients with amyotrophic lateral sclerosis (ALS), a Phase 1 trial shows. Read more about it here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.